Module 12-3: What Happens After a Clinical Trial Ends? (16 mins, Audio Only)

In this module, we explore how pragmatic trial teams can finish studies responsibly while supporting sites, staff, patients, and communities through the transition after a trial ends. The discussion covers why close-out planning matters, how de-implementation helps sites return to usual care or pause trial workflows, and why clear communication is essential before final results are available.

No Slides for this Module

** The video's content was generated with the assistance of artificial intelligence, with human guidance and oversight throughout the process. **

Close-Out Checklist (Document)

This study close-out checklist helps pragmatic trial teams plan, track, and document key close-out activities, including readiness, source documents, data management, safety reporting, regulatory closure, trial materials, samples, finance, archiving, and lessons learned. Users can adapt it to their protocol, jurisdiction, sponsor, REB, and institutional requirements for orderly study completion.

Content adapted from the NIDCR Study Close-Out Checklist, Template Version 2.0, 03JUL2013.